Emergency Service Hospital Prenotification Ups Stroke Tx

Share this article:
Emergency Service Hospital Prenotification Ups Stroke Tx
Emergency Service Hospital Prenotification Ups Stroke Tx

(HealthDay News) – Emergency medical service (EMS) hospital prenotification results in more timely imaging and administration of tissue plasminogen activator (tPA) and an increased proportion of eligible patients with acute ischemic stroke receiving tPA.

Cheryl B Lin, from the Duke-National University of Singapore Graduate Medical School, and colleagues examined 371,988 patients with acute ischemic stroke who were transported by EMS and enrolled in Get With The Guidelines-Stroke from April 2003–March 2011.

The researchers found that hospital prenotification occurred for 67.0% of EMS-transported patients. Patients with EMS prenotification who arrived within two hours were significantly more likely to be treated with tPA within three hours. Significantly shorter door-to-imaging times (26 vs. 31 minutes), door-to-needle times (78 vs. 80 minutes), and symptom onset-to-needle times (141 vs. 145 minutes) were seen for those with EMS prenotification. Based on multivariate analysis that accounted for clustering of patients within hospitals, use of EMS prenotification was independently associated with increased likelihood of door-to-imaging times ≤25 minutes, door-to-needle times for tPA ≤60 minutes, onset-to-needle times ≤120 minutes, and tPA use within three hours.

"These findings support the need for initiatives targeted at improving EMS prenotification rates nationally as a mechanism for improving acute ischemic stroke quality of care and outcomes," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs